Literature DB >> 10968369

Production and characterization of antibodies directed against the human melatonin receptors Mel-1a (mt1) and Mel-1b (MT2).

D Angeloni1, R Longhi, F Fraschini.   

Abstract

We report the production of polyclonal antibodies directed against the human melatonin receptors Mel-1a (mt1) and Mel-1b (MT2) by means of antigenic synthetic peptides with sequences unique to these proteins. Immunostaining on NIH3T3 cells stably transfected with Mel-1a and Mel-1b cDNA gave intense reactions. Neither the preimmune serum nor cross-tested antisera showed any reactivity. These polyclonal antibodies will be essential immunocytochemical tools to study the human melatonin receptors distribution at subcellular level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968369

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  3 in total

1.  Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.

Authors:  Daniel J van Wamelen; N Ahmad Aziz; Jasper J Anink; Robin van Steenhoven; Debora Angeloni; Franco Fraschini; Ralf Jockers; Raymund A C Roos; Dick F Swaab
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

Review 2.  Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.

Authors:  Stefano Comai; Gabriella Gobbi
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

3.  MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.

Authors:  Sara Mariotti; Ivana Barravecchia; Carla Vindigni; Angela Pucci; Michele Balsamo; Rosaliana Libro; Vera Senchenko; Alexey Dmitriev; Emanuela Jacchetti; Marco Cecchini; Franco Roviello; Michele Lai; Vania Broccoli; Massimiliano Andreazzoli; Chiara M Mazzanti; Debora Angeloni
Journal:  Oncotarget       Date:  2016-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.